Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials-Reference-Cited by-同舟云学术

Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials

Published:2022-01 Issue: Volume:160 Page:140-149
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van Dam Jacob L.^ORCID,Janssen Quisette P.^ORCID,Besselink Marc G.,Homs Marjolein Y.V.,van Santvoort Hjalmar C.,van Tienhoven Geertjan,de Wilde Roeland F.,Wilmink Johanna W.,van Eijck Casper H.J.,Groot Koerkamp Bas

Funder

Servier

Celgene

Meso Scale Diagnostics

Merck

Novartis

Shire

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018;Ferlay;Eur J Cancer,2018

3. NCCN clinical practice guidelines in oncology: pancreatic adenocarcinoma (Version 1.2020),2019

4. Diagnosis and management of pancreatic cancer in adults: a summary of guidelines from the UK National Institute for Health and Care Excellence;O'Reilly;Pancreatology,2018

5. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer;Versteijne;Br J Surg,2018

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical Complications After Neoadjuvant Treatment for Borderline Resectable Pancreatic Cancer: From Benchmarks to Randomized Clinical Trials;Annals of Surgical Oncology;2024-08-31

2. Prevalence of autoimmune pancreatitis in pancreatic resection for suspected malignancy: a systematic review and meta-analysis;BMC Gastroenterology;2024-08-21

3. Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes;International Journal of Molecular Sciences;2024-08-20

4. Safety and feasibility of percutaneous abdominal lavage cytology screening (PACS) prior to surgical resection for pancreatic cancer;Abdominal Radiology;2024-08-09

5. Extracellular vesicles miR‐31‐5p promotes pancreatic cancer chemoresistance via regulating LATS2‐Hippo pathway and promoting SPARC secretion from pancreatic stellate cells;Journal of Extracellular Vesicles;2024-08